HCPCS code Q5098 — Inj ustekinumab-srlf, 1 mg. Status: Active. Effective Jul 1, 2025. Source: CMS HCPCS Level II.

Q5098

Active

Inj ustekinumab-srlf, 1 mg

Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jul 1, 2025
Code type: alphanumeric
OPPS Status: E1 — Items / services not paid by Medicare

MUE — Medically Unlikely Edits

Maximum units of Q5098 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 520
Outpatient Hospital 520
Practitioner Services 520

Source: CMS Medicare NCCI Medically Unlikely Edits

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q3
    Inj ustekinumab-srlf, 1 mg